Have a question or topic idea for The Life Science Report? Submit it here.
Preparing BioPharma and Medtech Companies for Public Listing Back Bay Life Science Advisors and Nasdaq Nordic
The Nordic Nasdaq system—specifically the Stockholm markets—recently unveiled access to US biopharma and medtech companies to list on the Stockholm Exchange, either primarily or as a dual listing.
In this episode Jonathan Gertler and Maria Groschopp Dellwik of Nasdaq talk through how this recent policy shift could change the game for Nordic and US companies and their best practices for companies preparing to go public.
Subscribe:
Apple Podcasts | Libsyn | Spotify | Stitcher
